| 期 |
标题 |
文件 |
| 卷 10, 编号 6 (2024) |
Oxidative stress in chronic obstructive pulmonary disease: Pathogenetic and clinical aspects |
|
|
Budnevsky A., Avdeev S., Kravchenko A., Vostrikova K.
|
| 卷 9, 编号 5 (2023) |
Optimization of corticosteroid therapy for myastenia gravis |
|
|
Romanova T., Poverennova I., Persteneva N.
|
| 卷 9, 编号 8 (2023) |
Experience of a multidisciplinary approach to the treatment of comorbid pathology patient |
|
|
Vladimirova N., Myasnikova E., Shunaev V., Komleva G., Pikunova I., Peredelkina A.
|
| 卷 9, 编号 6 (2023) |
Experience of use of vaccination against pneumococcal infection (Prevenar 13) in patients with chronic non-specific diseases in the Republic of Sakha (Yakutia) |
|
|
Argunova A., Emelyanova E.
|
| 卷 10, 编号 1 (2024) |
Experience of dapagliflozin use in elderly female patients with hyperactive urinary bladder |
|
|
Yuzhakova E., Smirnova E.
|
| 卷 10, 编号 3 (2024) |
Experience of use and perspectives of carbocysteine in respiratory tract pathology treatment |
|
|
Vertkin A., Knorring G., Shamuilova M.
|
| 卷 10, 编号 7 (2024) |
Experience of using mometasone in seasonal allergic rhinitis patients |
|
|
Gappoeva E.
|
| 卷 10, 编号 5 (2024) |
Orthostatic hypotension in patients with arterial hypertension and carbohydrate metabolism disorders |
|
|
Antropova O., Nazarova V., Voloshina U.
|
| 卷 10, 编号 5 (2024) |
Complicated or uncomplicated hypertension crisis: puzzling aspects of clinical practice |
|
|
Bursikov A., Valiullina E., Kulikov I.
|
| 卷 9, 编号 2 (2023) |
Examination of the oral cavity as an important diagnostic tool of a primary care physician |
|
|
Gazdanova A., Plieva A., Solovieva S., Ponomarenko T.
|
| 卷 9, 编号 5 (2023) |
Basic concepts of sociomedical expertizing. Part 1: procedure of sociomedical expertizing referral, criteria of disability |
|
|
Lygina E., Yakushin S.
|
| 卷 9, 编号 6 (2023) |
Basic concepts of medical and social expertise. Part 2: procedure for carrying out medical and social examination of a person |
|
|
Lygina E., Yakushin S.
|
| 卷 9, 编号 9 (2023) |
Peculiarities of outpatient glycemic profile of patients with type 2 diabetes mellitus during innovative sugar-reducing therapy combined with metformin according to flash glucose monitoring data |
|
|
Teplova A., Demidova T., Lobanova K.
|
| 卷 10, 编号 3 (2024) |
Peculiarities of management of pregnant patients having inflammatory bowel diseases in hospital conditions: Literature review |
|
|
Knyazev O., Kagramanova A., Fadeeva N., Shkurko T.
|
| 卷 11, 编号 5 (2025) |
Peculiarities of the choice of therapy for inflammatory bowel diseases associated with malignant neoplasms |
|
|
Barysheva O., Golubeva A., Egorova K., Vezikova N., Varlamova D.
|
| 卷 11, 编号 6 (2025) |
Peculiarities and prognostic significance of nutritional status in fragile patients with chronic heart failure |
|
|
Moiseyeva A., Al Autairi A., Chopanova A., Yakovenko V., Kobalava Z.
|
| 卷 9, 编号 10 (2023) |
Peculiarities of clinical and radiological parameters, indexes of systemic inflammation and immune status in vaccinated patients with COVID-19 |
|
|
Mineeva E., Demko I., Sobko E., Kruglova O., Kudryavtsev Y.
|
| 卷 10, 编号 5 (2024) |
Peculiarities of clinical manifestations of helicobacter pylori infection in healthcare professionals |
|
|
Luzina E., Lazebnik L., Lareva N., Zhilina A., Moskvitina A.
|
| 卷 10, 编号 8 (2024) |
Peculiarities of the clinical course of myocardial infarction associated with malignant neoplasms of various stages and localizations at the hospital period |
|
|
Skorodumova E., Skorodumova E., Kostenko V., Siverina A.
|
| 卷 9, 编号 1 (2023) |
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 1: main limitations and adverse effects of medicamentous therapy |
|
|
Lyalina V., Skripnichenko E., Borisovskaya S., Obyedkov R., Nikitin I.
|
| 卷 9, 编号 2 (2023) |
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 2: management of patients with cardiovascular, gastrointestinal, renal, liver diseases, pregnancy, also having anticoagulant therapy and patients in perioperative period |
|
|
Lyalina V., Skripnichenko E., Borisovskaya S., Obyedkov R., Nikitin I.
|
| 卷 10, 编号 3 (2024) |
Peculiarities of lipid metabolism and vascular wall rigidity in ulcerative colitis patients |
|
|
Kucherova N., Tsyganova Y., Tarasova L.
|
| 卷 11, 编号 3 (2025) |
Peculiarities of metabolically healthy obesity among the population aged 45–69 |
|
|
Berezenko I., Filippov E., Volchenkova M.
|
| 卷 9, 编号 6 (2023) |
Features of nutritional support in diseases of the bronchopulmonary system |
|
|
Pilat T., Kuzmina L., Kolyaskina M., Anvarul N.
|
| 卷 9, 编号 9 (2023) |
Peculiarities of nutrition in pregnant females with different subtypes of gestational diabetes mellitus |
|
|
Davidenko I., Sorokina Y., Volkova N., Degtyareva Y., Kovalenko V., Golubev M.
|
| 卷 10, 编号 2 (2024) |
Peculiarities of food sensitization in patients having bronchial asthma in combination with Helicobacter pylori-associated chronic gastritis |
|
|
Pozdnyakova O., Dyshekova N., Dokhkaeva A.
|
| 卷 10, 编号 2 (2024) |
Peculiarities of multi-component subscutaneous allergen-specific immunotherapy with weed allergens performing |
|
|
Shogenova M., Khutueva S., Shogenova L.
|
| 卷 9, 编号 4 (2023) |
Special features of the psycho-emotional state of comorbid patients in therapist’s practice: what is important to take into consideration in their curation tactics |
|
|
Shishkova V.
|
| 卷 11, 编号 7 (2025) |
Peculiarities of the development and clinical course of fibromyalgia in male individuals |
|
|
Teplyakova O., Shalaginova D., Pastukhova V.
|
| 卷 11, 编号 2 (2025) |
Peculiarities of the daily profile of arterial pressure and vascular stiffness in arterial hypertension and chronic heart failure patients with senile asthenia syndrome |
|
|
Safronenko V., Chesnikova A.
|
| 卷 9, 编号 7 (2023) |
Peculiarities of COVID-19 clinical course in patients with various rheumatic diseases |
|
|
Mukhamadieva V., Shamsutdinova N., Abdulganieva D., Adrakipov R., Mukhina R., Dyakova E., Sukhorukova E.
|
| 卷 11, 编号 2 (2025) |
Peculiarities of the clinical course and risk factors of long-lasting post-COVID syndrome in patients with shortness of breath |
|
|
Masalkina O., Polyanskaya E., Koziolova N., Chernyavina A.
|
| 卷 11, 编号 1 (2025) |
Features of the course of osteoarthritis in patients with asymptomatic hyperuricemia |
|
|
Bashkinov R., Mazurov V., Gaydukova I., Inamova O., Petrova M.
|
| 卷 9, 编号 1 (2023) |
Peculiarities of the course of rheumatoid arthritis in patients with thrombocytosis and comorbid conditions |
|
|
Mazurov V., Melnikov E., Morozova K., Evgrafova V.
|
| 卷 11, 编号 7 (2025) |
Knee joint osteoarthritis and myofascial pain syndrome: diagnosis, pathogenesis, and therapeutic approaches |
|
|
Shokhin A., Trofimova A., Trofimov E., Gaydukova I.
|
| 卷 10, 编号 4 (2024) |
Acute heart failure – An EFIM guideline critical appraisal and adaptation for internists |
|
|
Kokorin V., Gonzalez-Franco A., Cittadini A., Kalejs O., Larina V., Marra A., Medrano F., Monhart Z., Morbidoni L., Pimenta J., Lesniak W.
|
| 卷 9, 编号 7 (2023) |
Acute bronchitis: main accents |
|
|
Leshchenko I., Malyavin A., Zaitsev A., Esaulova N.
|
| 卷 11, 编号 4 (2025) |
Acute bronchitis: a modern view at diagnosis and treatment |
|
|
Budnevsky A., Avdeev S., Ovsyannikov E., Feigelman S., Budnevskaya S.
|
| 卷 9, 编号 10 (2023) |
From empirical medicine – to analytical medicine |
|
|
Volkova N., Volkov A.
|
| 卷 9, 编号 3 (2023) |
Evaluation of safety of bioactive concentrate of small marine fish in senile patients with knee osteoarthritis and high comorbidity rates |
|
|
Malyshenko O., Taskina E., Raskina T., Averkieva Y., Usova E., Koroleva M., Letaeva M.
|
| 卷 10, 编号 8 (2024) |
Estimation of extended medical examination coverage indexes in young individuals after novel coronavirus infection |
|
|
Ushakova E., Pakhomova Y., Kladovikova O., Larina V.
|
| 卷 10, 编号 9 (2024) |
Estimation of adherence to treatment among patients with arterial hypertension based on therapeutic drug monitoring data |
|
|
Seleznev S., Mylnikov P., Shchulkin A., Yakushin S.
|
| 卷 10, 编号 9 (2024) |
Estimation of the prognostic role of patients’ adhesion to treatment and Charlson comorbidity index as predictors of chronic heart failure decompensation |
|
|
Pyrikova N., Mozgunov N., Osipova I., Molchanova A.
|
| 卷 10, 编号 1 (2024) |
Estimation of the risk of cardiovascular events and adverse outcomes in patients with peripheral atherosclerosis |
|
|
Kobzeva N., Demidova A., Shlyk S., Martynov A., Shlyk I.
|
| 卷 9, 编号 6 (2023) |
Calculation of cardiovascular risk in patients with premature ovarian insufficiency depending on its etiology |
|
|
Lopukhov S., Nikiforov A., Filippov E.
|
| 卷 11, 编号 2 (2025) |
Estimation of the spectrum and severity of COVID-19-associated metabolic changes in patients with non-alcoholic fatty liver disease |
|
|
Zhuk K., Tarlovskaya E., Vlasova T.
|
| 卷 10, 编号 7 (2024) |
Estimation of the platelet component of hemostasis in COVID-19 patients |
|
|
Kadnikov L., Izmozherova N., Popov A., Antropova I.
|
| 卷 11, 编号 8 (2025) |
Estimation of galectin-3 level in female patients with chronic heart failure, type 2 diabetes mellitus, and asymptomatic hyperuricemia |
|
|
Kolpacheva M., Pashkova A., Antakova L., Gerasimova O., Alferova E.
|
| 卷 9, 编号 9 (2023) |
Assessment of physical activity level in patients with asthma depending on body weight |
|
|
Tribuntceva L., Avdeev S., Budnevsky A., Choporov O., Prozorova G., Olysheva I.
|
| 卷 9, 编号 2 (2023) |
Evaluation of the efficacy of probiotic medicines including in the therapy of patients with post-infectious irritable bowel syndrome after COVID-19 infection surviving |
|
|
Didigova R., Evloeva D., Ugurchieva P., Malsagova I., Khamkhoeva F., Bokova M.
|
| 卷 10, 编号 7 (2024) |
Estimation of the efficacy of probiotic cocktails in correcting intestinal microbial-tissue barrier and subjective well-being of convalescents who have survived mild forms of COVID-19 |
|
|
Gurovskikh A., Grigorovich M.
|
| 卷 10, 编号 9 (2024) |
Estimation of the efficacy of therapy at the outpatientpolyclinic stage of observation in patients who have suffered from acute myocardial infarction (according to the PROFILE-IM register data) |
|
|
Kalaydzhyan E., Kutishenko N., Lukina Y., Sichinava D., Martsevich S., Drapkina O.
|
| 卷 10, 编号 3 (2024) |
In memory of Galina Nikolaevna Gorokhovskaya (1935–2024) |
|
|
Editorial B.
|
| 卷 9, 编号 7 (2023) |
COVID-19 pandemic and the state of kidney function |
|
|
Abyzov A., Kichigin V., Savvateeva O.
|
| 卷 10, 编号 1 (2024) |
Panniculitis: Aspects of diagnosis |
|
|
Egorova O., Tarasova G., Lila A.
|
| 卷 9, 编号 9 (2023) |
Paraneoplastic thromboendocarditis: Analysis of three cases in patients with gastric tumor lesion |
|
|
Yagoda A., Gladkikh N., Koroy P., Rybas A.
|
| 卷 10, 编号 7 (2024) |
Pathogenesis of virus-induced inflammation: from theory to development and implementation of a new paradigm of medicinal remedies |
|
|
Ostroumova O., Dubinina A., Telkova S., Gavrilova N., Sinitsina I., Malyavin A.
|
| 卷 9, 编号 6 (2023) |
Pathogenetic therapy of pulmonary hypertension |
|
|
Tsareva N., Khachaturov M., Avdeev S.
|
| 卷 9, 编号 2 (2023) |
Pathogenetic therapy in case of COVID-19: decreasing of key hyper inflammatory response factors production |
|
|
Nikolaeva S.
|
| 卷 9, 编号 7 (2023) |
Pathogenetic approaches to combined pharmacotherapy of cough syndrome |
|
|
Mubarakshina O., Somova M., Batishcheva G.
|
| 卷 9, 编号 9 (2023) |
Pathology of carbohydrate metabolism in primary hyperparathyroidism: Epidemiological and clinical characteristics |
|
|
Bibik E., Dobreva E., Eremkina A., Mokrysheva N.
|
| 卷 11, 编号 1 (2025) |
Patient with overactive urinary bladder at a therapist’s appointment: algorithm of assistance |
|
|
Mubarakshina O., Batishcheva G., Dronova Y., Chernov S.
|
| 卷 10, 编号 2 (2024) |
Coughing patient at physician’s appointment: step-by-step instructions for diagnosis and treatment |
|
|
Berns S., Smirnova M.
|
| 卷 9, 编号 9 (2023) |
Patient with non-alcoholic fatty liver disease at care encounter of a therapist: Aspects of diagnostics and treatment |
|
|
Turkina S., Statsenko M., Kosivtsova M., Titarenko M., Tyshchenko I.
|
| 卷 10, 编号 7 (2024) |
Patient with primary systemic amyloidosis: a difficult way to diagnosis |
|
|
Eremina E., Strokova O., Zvereva S.
|
| 卷 9, 编号 6 (2023) |
Patient-oriented approach in the choice of treatment strategy in internal diseases clinic |
|
|
Verushkina A., Efremova E.
|
| 卷 9, 编号 4 (2023) |
Patients with cardiovascular diseases and NSAIDs intake: is there a real problem today? |
|
|
Rebrov A., Tyapkina M., Ordyakova A., Yupatov V., Kosheleva N., Basov I.
|
| 卷 10, 编号 6 (2024) |
Primary screening of obstructive sleep apnea in patients with acute coronary syndrome |
|
|
Evdokimov D., Fizikova A., Rukavichnikova A., Resnyanskaya E.
|
| 卷 9, 编号 7 (2023) |
Perspectives for the use of nanotechnologies in Helicobacter pylori eradication |
|
|
Bakulina N., Savilova I., Lutaenko E., Tsurtsumiya D.
|
| 卷 11, 编号 8 (2025) |
Duodenal digestive function in the treatment of patients with chronic duodenal insufficiency |
|
|
Vakhrushev Y., Busygina M., Khokhlacheva N.
|
| 卷 9, 编号 10 (2023) |
According to the reports of the XVIII National Congress of Internal Medicine: ARVI – myths and facts |
|
|
Editorial B.
|
| 卷 9, 编号 10 (2023) |
According to the reports of the XVIII National Congress of Internal Medicine: Liver and essential phospholipids |
|
|
Editorial B.
|
| 卷 9, 编号 6 (2023) |
Based on materials of community-acquired pneumonia – an European Federation of internal medicine guideline critical appraisal adaptation for internists: important answers to difficult questions |
|
|
Kokorin V., Larina V., Lunev D., Suvorova N.
|
| 卷 10, 编号 9 (2024) |
Side effects of systemic interferon-containing drugs |
|
|
Chervinets Y., Belyaev V., Yukhimets M., Nasser A., Pogosyan A.
|
| 卷 9, 编号 6 (2023) |
Injuries of thoracic cage |
|
|
Zaitsev A., Davydov D., Chuprina A., Sergoventsev A., Malyavin A.
|
| 卷 9, 编号 7 (2023) |
Improving the effectiveness of rehabilitation treatment of a patient who has suffered an ischemic stroke |
|
|
Kamchatnov P., Prikazchikov S., Osmaeva Z., Chugunov A.
|
| 卷 10, 编号 2 (2024) |
Approaches to diagnostics, differential diagnosis and treatment of anemia in therapeutic practice |
|
|
Telkova S., Batyukina S., Gavrilova N., Klepikova M., Ostroumova O.
|
| 卷 11, 编号 3 (2025) |
Late diagnosis of primary hyperaldosteronism in outpatient practice |
|
|
Shcherbina E., Larina V.
|
| 卷 11, 编号 5 (2025) |
Search for molecular markers in patients with familial hypercholesterolemia in Chuvash population |
|
|
Tarasova L., Porfiryeva L., Dubova A., Kucherova N., Dimitrieva O.
|
| 卷 9, 编号 3 (2023) |
Indicators of systemic inflammation and state of the cardiovascular system in patients with chronic kidney disease |
|
|
Zhmurov D., Zhmurov V., Petrov I., Petelina T., Gapon L., Yaroslavskaya E., Petrova Y., Oskolkov S., Zhmurova E., Vanuito E., Ermakova A., Ermakova P.
|
| 卷 9, 编号 8 (2023) |
Indexes of left ventricle contractive function in persons after acute coronary event, depending on the presence of diabetes mellitus and sodium-glucose transporter inhibitors type 2 use |
|
|
Nevzorova V., Semenova P., Zakharchuk N., Ivina A.
|
| 卷 11, 编号 8 (2025) |
Polyvalent drug allergy or hypersensitivity to macrogol? |
|
|
Shiyanov D., Baturina M.
|
| 卷 10, 编号 2 (2024) |
Polymorphic variants of renin-angiotensin-aldosterone system genes in female patients with a history of arterial hypertension during pregnancy and their association with metabolic syndrome |
|
|
Tarasova O., Chulkov V., Ektova N., Chulkov V.
|
| 卷 11, 编号 3 (2025) |
Polyneuropathy in Sjogren’s syndrome – a long path from symptom to diagnosis |
|
|
Ostapchuk E., Gorbachevsky A., Vorobyev A.
|
| 卷 9, 编号 6 (2023) |
Lung damage in rheumatoid arthritis: complex points of clinical practice |
|
|
Beketova M., Georginova O., Krasnova T.
|
| 卷 9, 编号 5 (2023) |
Damage of nervous system in COVID-19: Neuropsychological syndromes, histological data |
|
|
Mashin V., Belova L., Dudikov E., Slesareva E., Dolgova D., Nikishin K., Lyalchenko Y.
|
| 卷 11, 编号 3 (2025) |
Prediabetes as a therapist’s area of responsibility |
|
|
Volkova N., Davidenko I., Repchenko D.
|
| 卷 10, 编号 9 (2024) |
Prediabetes: Therapy of carbohydrate metabolism disorders in patients with risk factors |
|
|
Malyavin A., Mkrtumyan A., Adasheva T., Bolieva L.
|
| 卷 9, 编号 1 (2023) |
Predictors of cardiovacular risk as prognostic factors of adverse course and outcomes of COVID-19 in young and middle age adults |
|
|
Bratilova E., Kachnov V., Tyrenko V., Afonaskov O.
|
| 卷 10, 编号 3 (2024) |
Predictors of creatininemia in locomotive crew workers: Prospective observational study |
|
|
Lazutkina A.
|
| 卷 11, 编号 2 (2025) |
Predictors of anemia development in long-lasting post-COVID syndrome |
|
|
Koziolova N., Chernyavina A., Masalkina O., Sosnin D.
|
| 卷 10, 编号 5 (2024) |
Benefits and problems of physical activity during the COVID-19 pandemic |
|
|
Grigor’eva I.
|
| 卷 10, 编号 8 (2024) |
Advantages of combined use of sodium-glucose co-transporter type 2 inhibitors and glucagon-like peptide-1 receptor agonists relatively to cardiovascular and renal outcomes in patients with type 2 diabetes mellitus |
|
|
Salukhov V., Shustov S., Petrankov K.
|
| 卷 10, 编号 7 (2024) |
Treatment adherence in patients after orthognathic surgery |
|
|
Tanashyan M., Maksimova M., Lagoda O.
|
| 卷 11, 编号 8 (2025) |
Using N-acetylcysteine for cough associated with seasonal respiratory viral infection complicated by acute bronchitis |
|
|
Berns S.
|
| 卷 10, 编号 7 (2024) |
Use of apixaban for prevention of a secondary brain stroke in patients with atrial fibrillation |
|
|
Kasimova A., Tufanova O.
|
| 卷 11, 编号 3 (2025) |
Use of acetylsalicylic acid and its combined forms in real clinical practice |
|
|
Borisov A., Kasimova A.
|
| 卷 9, 编号 3 (2023) |
Use of dapagliflozin in a comorbid patient: new opportunities |
|
|
Panevin T., Eliseev M., Bobkova A., Dimitreva A., Urumova M.
|
| 卷 9, 编号 4 (2023) |
Should the application of clinical guidelines be mandatory or recommendatory? |
|
|
Nikolaev N.
|
| 卷 9, 编号 7 (2023) |
The use of Alflutop® in real clinical practice: results of a multicenter prospective observational study |
|
|
Lila A., Strebkova E., Alekseeva L., Taskina E., Kashevarova N.
|
| 301 - 400 的 570 信息 |
<< < 1 2 3 4 5 6 > >> |
